At A Glance
Pharma marketers can support more informed health journeys when patient and HCP messaging is relevant, privacy-forward, and optimized against meaningful outcomes. In this Ask the Expert conversation, Experian and DeepIntent discuss how health marketers can coordinate education, CTV, activation workflows, and measurement without entering private clinical decisions.Privacy-forward pharma media supports more informed healthcare journeys
Effective pharma marketing depends on reaching patients, caregivers, and healthcare professionals (HCPs) with useful information in appropriate, privacy-forward ways. The goal is to make relevant education easier to find, support more informed conversations, and help brands understand how media contributes across the health journey.
In this Ask the Expert session, Natalie Mancuso, SVP, Data Partnerships at DeepIntent, joins Sheila Wirick, who leads the health team at Experian, to discuss how to craft patient and HCP campaigns, privacy-safe activation workflows, connected TV (CTV), and measurement approaches built for pharma.
Why should your media plan start with understanding the patient and provider
The patient-and-provider journey should inform your media plan, as treatment decisions in pharma are increasingly informed, personal, and patient-driven. With more health information available than ever, patients are playing a more active role in understanding their options and participating in treatment conversations. As other industries become more customer-centric, pharma media planning needs to become more patient-centric.
“We’ve got patients who are more informed, more involved in their treatment decisions than ever. The accessibility of data and information and the ways we can consume it with just AI alone is so vast that if we’re not arming people with the right information in real time, we’re missing the boat.”
DeepIntentNatalie Mancuso, SVP, Data Partnerships
This means media should be aligned to where a patient or provider is in the decision journey and what they need at that moment. Early on, media may play an educational role by building awareness of a condition, symptom, or treatment category. Later, it may help support more specific questions, treatment consideration, access, affordability, or adherence.
The patient-provider conversation remains the key boundary. That exchange should stay private and clinically led. Media can play a valuable role before and after those moments by offering information that helps patients and providers feel more informed.
How can brands connect patient and HCP messaging responsibly?
It’s critical for agencies and brands to deliver relevant messaging to inform each stakeholder’s needs throughout the treatment journey, especially ahead of key clinical milestones. To execute this, brands must exercise privacy-forward activation, keeping patient and HCP identity, activation, and measurement paths separate, while using a common workflow layer to support the same brand goal.
Experian helps pharma marketers do this by acting as an independent, privacy-forward identity, data, and workflow layer. We bring together high-fidelity matching, governed onboarding, and non-clinical consumer context, so patient and HCP engagement can be activated more accurately across channels and connected to reporting.
The distinction is not only where each audience is reached. HCPs may be engaged in both professional and personal environments, but their needs are different from patients’. For example, an HCP may receive messaging about co-pay savings for eligible patients, while a patient may receive information about patient support programs. These are different messages for different audiences, but they ladder up to the same goal: informing both parties in a privacy-forward, relevant way.
Hear from Natalie Mancuso in our 2026 State of advertising report
In our 2026 State of advertising report, Natalie shares why identity serves as the connective infrastructure that links planning, activation, and measurement across connected TV (CTV), programmatic, commerce media, and walled garden environments.
What does privacy-forward activation look like in pharma?
Pharma brands often start with fragmented patient and HCP signals. Privacy-forward activation turns those inputs into usable audiences by first confirming that the data can be used, then translating identity in controlled environments that protect personally identifiable information through tokenization or other methodologies.
For DTC, that means building and matching audiences without relying on inferred health conditions from browsing behavior. For HCPs, it means connecting professional identity to verified sources in a way that supports activation and measurement. In a category shaped by HIPAA, state privacy laws, internal review, and consumer sensitivity, building privacy in from sourcing through activation is what makes responsible health media possible.
How can CTV play a more useful role in pharma?
CTV can play a more useful role in healthcare when it’s connected to a larger, privacy-forward plan and not treated as just an awareness channel.
DeepIntent connects CTV and digital exposure data using identity signals, such as National Provider Identifiers (NPIs), hashed email addresses, IP addresses, device IDs, and household signals, where permitted and reviewed. That identity layer helps support sequencing and suppression across streaming, endemic, mobile, and digital settings.
In practice, CTV can introduce targeted education or broad brand awareness, and later touchpoints can provide sequential information in the right channels. Instead of repeating the same message, brands can make pivots based on engagement and context.
“For us, it starts with identity and not panels. When we’re resolving CTV and digital exposures to the same person, we’re leveraging signals so that every touchpoint across streaming, endemic, and mobile is recognized as the same individual, not model lookalikes.”
DeepIntentNatalie Mancuso, SVP, Data Partnerships
For pharma, campaign performance should not be measured by reach alone. A stronger approach looks at whether sequenced engagement contributes to meaningful downstream signals, including:
- Prescription activity
- Provider engagement
- Referral patterns
- Patient compliance
- Adherence signals, where measurement is permitted
Why should messaging and reporting change in pharma?
Pharma campaigns are journeys with changing information needs. Reporting should guide the campaign optimization.
“If I’m launching into a market with a new class of drug, I’m asking what education needs to be put into the market – from both an HCP and a consumer standpoint – to build awareness?”
DeepIntentNatalie Mancuso, SVP, Data Partnerships
Clicks and website visits still have a place, but they can’t tell the full pharma story. DeepIntent processes data in real time, giving brands an up-to-date read on how media connects to campaign engagement. Campaign signals can help teams optimize audience logic, creative, channel mix, or sequencing during a live campaign.
Explore how privacy-safe pharma activation can make an impact
Experian brings marketing data and identity expertise for health marketing and DeepIntent adds pharma-specific activation experience. Together, we help brands connect patient and HCP strategies responsibly, with privacy built in from the start.
Watch the full video with our experts to hear Sheila Wirick and Natalie Mancuso discuss patient and HCP messaging, CTV, privacy-safe activation, and outcome measurement for pharma brands.
About our experts
Natalie Mancuso
SVP, Data Partnerships, DeepIntent
Natalie Mancuso is SVP, Data Partnerships at DeepIntent and a leader in health-focused AdTech and DSP strategy. With over 20 years of experience growing billion-dollar healthcare brands, she turns complex data into scalable, performance-driven solutions that keep marketers ahead of industry change.
Sheila Wirick
Director of Health Sales, Experian
Sheila Wirick is the Director of Health Sales at Experian with more than 20 years of experience in data and analytics. As Director of Health Sales at Experian Marketing Services, she collaborates with healthcare, pharmaceutical, and nonprofit organizations to apply data and insights that enhance customer retention, brand awareness, and acquisition. She is committed to helping organizations use data to deliver measurable results and meaningful impact.
FAQs
A pharma audience is activation-ready when patient or HCP inputs can be translated into usable audiences with the right accuracy, controls, interoperability, and destination readiness. For patient engagement, that may include privacy-safe cohort construction, caregiver logic, non-clinical enrichment and appropriate exclusion rules. For HCP engagement, it may include governed identity inputs such as NPI, specialty, practice location, professional address and other verified attributes where appropriate.
Pharma brands can sequence messages responsibly by giving each channel a clear role and using audience logic to maintain continuity. CTV and out-of-home can support awareness, social can reinforce the message, search can capture active research and point-of-care or rep-triggered channels can support decision moments. The workflow should preserve separation between patient and HCP identity strategies.
Pharma marketers should measure whether media connects to outcomes such as audience quality, prescription activity, qualified HCP engagement, verified delivery, referral patterns, therapy starts or adherence signals where permitted. These outcomes often depend on partner-enabled workflows, clean rooms, and aggregated outputs rather than direct end-to-end tracking.
Experian acts as an independent privacy-first identity, data, and workflow layer for pharma marketers. We help brands bring together identity, high-fidelity matching, governed onboarding, non-clinical consumer context, and partner interoperability so patient and HCP engagement can be activated more accurately across channels and connected more cleanly to partner-enabled measurement.
Latest posts
AcuityAds partners with Tapad, part of Experian, to enhance cross-device marketing capabilities with a focus on CTV
Featured storiesTapad, part of Experian, integrates with AcuityAds’ current offering will complement cross-channel capabilities for brands and agencies in the U.S. and Canada NEW YORK, Jan. 23, 2020 /PRNewswire/ — Tapad, a global leader in digital identity resolution, has partnered with AcuityAds, a technology leader that provides targeted digital media solutions for advertisers to connect intelligently with audiences. The partnership will enhance AcuityAds’ existing cross-device solution, especially with respect to its cross-channel Connected TV offering. Tapad’s global, privacy-safe digital cross-device solution, The Tapad Graph, will compliment AcuityAds’ own cross-device data set for enhanced marketing capabilities across their Demand Side Platform (DSP). For AcuityAds, this provides customers with unduplicated reach across desktop, tablet, mobile and CTV devices – while augmenting their video offering. Tom Woods, Vice President of Products at AcuityAds commented, “With increasing marketing complexities, consumer device usage and new data regulations, our decision regarding the partnership was an important one. The Tapad Graph’s privacy-safe identifiers for consumer notice and choice, as well as the ability to opt-out at any point, were critical factors in our decision who to partner with.” To learn more about Tapad and our digital identity resolution capabilities, visit our identity page. About Tapad Tapad, Inc. is a global leader in digital identity resolution. The Tapad Graph and its related solutions provide a transparent, privacy-safe approach connecting brands to consumers through their devices globally. Tapad is recognized across the industry for its product innovation, workplace culture, and talent, and has earned numerous awards including One World Identity’s 2019 Top 100 Influencers in Identity Award. Headquartered in New York, Tapad also has offices in Chicago, London, Oslo, Singapore, and Tokyo. About AcuityAds AcuityAds is a leading technology company that provides marketers a powerful and holistic solution for digital advertising across all ad formats and screens to amplify reach and Share of Attention® throughout the customer journey. Via its unique, data-driven insights, real-time analytics and industry-leading activation platform based on proprietary Artificial Intelligence technology, AcuityAds leverages an integrated ecosystem of partners for data, inventory, brand safety and fraud prevention, offering unparalleled, trusted solutions that the most demanding marketers require to be successful in the digital era. AcuityAds is headquartered in Toronto with offices throughout the U.S., Europe and Latin America. For more information, visit AcuityAds.com. Disclaimer in regards to Forward-looking Statements Certain statements included herein constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Except as required by law, AcuityAds does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events. Contact us today
Tapad, a part of Experian and the future of cookies Earlier this week, Google announced plans to create “.. a path towards making third-party cookies obsolete”; which will result in the phasing out of support for third-party cookies in its Chrome browser within two years. While there has been much discussion and debate on the future of the third-party cookie, an announcement from Google has been anticipated for some time. As many have said this week, the use of cookies and other identifiers has and will continue to evolve. What will never change is the value exchange between publishers and consumers that is enabled by relevant advertising. Notably, the need for independent companies to develop solutions that enable this value exchange has never been greater to ensure that publishers, consumers, and advertisers derive the most value from their relationship. We are well-positioned for the future From the start, Tapad, a part of Experian has led with a consumer-first, privacy-centric approach to technology as the use and proliferation of devices and global privacy regulations continue to evolve. Over the past two years, Tapad, a part of Experian has gone through a technical overhaul. Calling on almost ten years of expertise in identity resolution, we have created a modern platform that is flexible in terms of identity input as well as output. Anticipated change in the identity landscape was the driver behind our architecture decisions and what enables us to be responsive to a dynamic market. Consumer behavior and device use continue to change, bringing additional digital IDs into the equation – namely across the mobile and CTV environments. Our technology, however, is not tied to any specific type of identifier, but rather is focused on associating disparate identifiers at the individual and household level. Where do we go from here? Google’s announcement has been characterized as a conversation starter, but we see it more as a call to action. With a timeline set, there is a need to converge on one or more solutions that can scale across the web. In a post cookie world, publishers and advertisers will continue to require ways to create fair marketplaces across platforms and devices. Further, the platforms that currently power the programmatic advertising ecosystem will need to be able to invest and differentiate to bring value to their customers. Scaled privacy-safe identity solutions will be needed not only for classic targeting, attribution, measurement, and frequency capping use cases but also to carry consumer preferences and consent. Tapad, a part of Experian will continue to play a leading role here. However, we are not going to do this alone. As solutions around Google’s Chrome browser evolve, we will continue to take a leadership position and will work with Google, key industry groups, partners and customers to meet current and future needs for an independent identity solution at scale. In the meantime, we will continue to support an independent ecosystem where consumers come first and privacy standards are a priority. It’s business as usual…for now. There will not be any changes to our graph products or services as a result of Google’s announcement in the near term. Any changes related to the Chrome third-party cookie will evolve and will no doubt be subject to significant industry participation and feed-back, indeed at the invitation of Google. We will proactively communicate any changes and product updates during this time period. We look forward to the opportunities resulting from these changes and ushering in a new era of identity resolution in digital advertising. Contact us today
Knorex partners with Tapad, part of Experian, to enable enhanced cross-device marketing capabilities for brands and agencies
Featured storiesTapad’s integration with Knorex’s XPO™ platform will complement cross-channel optimization capabilities for brands and agencies in the U.S. and APAC markets NEW YORK and SINGAPORE, Dec. 10, 2019 /PRNewswire/ — Tapad, part of Experian and a global leader in digital identity resolution, has partnered with Knorex, a leading provider of digital performance marketing. Knorex’s self-service online advertising platform, Knorex XPO™, enables marketers to advertise globally in real-time across different media channels, formats, platforms and devices. Tapad’s global, privacy-safe digital cross-device solution, The Tapad Graph, will compliment Knorex XPO™’s own device data set for enhanced marketing capabilities. For Knorex, the integration enables their brand direct and agency customers to gain a more accurate understanding of consumers across devices to reduce campaign inefficiencies and duplication, and to effectively manage frequency capping and attribution. Abhishek Kumar, VP of Engineering at Knorex commented, “Today’s digital consumer is raising the bar for marketers. With increasing marketing complexities and consumer device usage, this integration enables marketers to understand the consumer decision journey with heightened ease. Our combined offering will empower agencies in the APAC and US markets, providing an improved marketing solution that will help to streamline their efforts.” Abhay Doshi, Head of APAC at Tapad added: “The Tapad Graph, when integrated with the Knorex XPO platform, should not only help U.S. and APAC marketers optimize campaign performance through cross device marketing – but also increase the opportunity for brands to reach out to their target customers within a desired time.” To learn more about Tapad and our digital identity resolution capabilities, visit https://www.experian.com/marketing/consumer-sync. About TapadTapad, Inc. is a global leader in digital identity resolution. The Tapad Graph and its related solutions provide a transparent, privacy-safe approach connecting brands to consumers through their devices globally. Tapad is recognized across the industry for its product innovation, workplace culture, and talent, and has earned numerous awards including One World Identity’s 2019 Top 100 Influencers in Identity Award. Headquartered in New York, Tapad also has offices in Chicago, London, Oslo, Singapore, and Tokyo. About KnorexKnorex provides programmatic advertising products and technologies to advertising buyers worldwide. With its cloud-based online advertising platform, Knorex XPO™ enables ad buyers to self-serve and advertise real-time across the globe regardless of the media channels (social, search, OTT/CTV, video, web/mobile etc.), ad formats (display, native, search, social, video etc) and devices (desktop, laptop, smartphones and tablets) to deliver personalized marketing messages to the target audience in an automated way, powered by machine learning/AI. Underpinned by a multi-layered data-driven approach, XPO simplifies the execution and optimization of marketing campaigns, while delivering measurable and attributable performance. Contact us today